Page last updated: 2024-08-16

meptazinol and scopolamine hydrobromide

meptazinol has been researched along with scopolamine hydrobromide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Ennis, C; Stephens, RJ1
Broadley, J; Robson, P; Wilson, T1
Chen, HZ; Cui, Y; Ge, XX; Li, J; Liu, T; Qiu, ZB; Wang, H; Xia, Z; Xie, Q; Xu, J; Xu, JR; Zhang, WW1
Chen, HZ; Ge, XX; Jiang, P; Le, WD; Lu, Y; Qiu, ZB; Shao, BY; Sun, J; Wang, H; Xia, Z; Xie, Q; Zhang, WW1

Trials

1 trial(s) available for meptazinol and scopolamine hydrobromide

ArticleYear
The use of meptazinol as a premedication for surgical patients.
    The Journal of international medical research, 1982, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Aged; Azepines; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Male; Meptazinol; Middle Aged; Opium; Preanesthetic Medication; Random Allocation; Respiration; Scopolamine; Surgical Procedures, Operative

1982

Other Studies

5 other study(ies) available for meptazinol and scopolamine hydrobromide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
A comparison of the effects of meptazinol and morphine on the release of acetylcholine from slices of mouse cerebral cortex.
    Neuropharmacology, 1984, Volume: 23, Issue:12A

    Topics: Acetylcholine; Animals; Azepines; Cerebral Cortex; Female; Kinetics; Meptazinol; Mice; Morphine; Oxotremorine; Scopolamine; Tetrodotoxin

1984
Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 104

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Brain; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Female; Humans; Kinetics; Male; Maze Learning; Memory Disorders; Meptazinol; Mice; Models, Molecular; Nootropic Agents; Scopolamine; Sesquiterpenes

2013
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.
    CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:2

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Drug Administration Schedule; Humans; Maze Learning; Meptazinol; Mice; Mice, Transgenic; Neuroblastoma; Phenylcarbamates; Presenilin-1; RNA, Messenger; Scopolamine

2014